Does sirolimus need to be refrigerated? Storage rules

Last updated 2026-07-27

Does sirolimus need to be refrigerated or kept at room temperature?

For the FDA-approved oral formulations, the answer is room temperature, not the fridge. Rapamune (sirolimus) tablets and oral solution are labeled to be stored at 20°C to 25°C (68°F to 77°F), with allowed excursions between 15°C and 30°C (59°F to 86°F) for things like shipping delays ^[1]. That's standard room temperature storage, the same range you'd use for most tablets in a medicine cabinet. The oral solution has one extra instruction: once opened, use it within 1 month, and keep it out of the refrigerator during that window if it was refrigerated in transit, per the product labeling maintained in FDA's approved prescribing information ^[1]. Refrigeration is not required for the tablets at all. Forcing tablets into the fridge doesn't add shelf life. It can also introduce condensation problems if you move them in and out repeatedly. Where it gets more complicated is off-label use. People sourcing sirolimus for longevity or anti-aging protocols sometimes get it as a compounded product, an injectable, or a reconstituted form from a specialty pharmacy rather than a manufacturer-sealed bottle of Rapamune. Those products can have their own stability data and their own storage instructions, which may include refrigeration before first use or after reconstitution. If you're working through a provider-reviewed pathway, the pharmacy that fills the prescription is the authority on that specific product's storage, not a general web article. Sirolimus Rx routes prescriptions through a licensed provider and pharmacy partner precisely so patients get product-specific handling instructions rather than guesswork.

What's the difference between storing tablets, oral solution and reconstituted sirolimus?

Three different physical forms, three different rulebooks. Sealed tablets are the simplest: room temperature, protected from moisture, and that's basically it. The manufacturer's label calls for storage in the original container and protection from light and moisture ^[1]. Oral solution is more sensitive. It ships refrigerated in some cases, but once you have the bottle at home you store it at room temperature and use it within 30 days of opening ^[1]. Beyond that window, potency isn't guaranteed and the manufacturer doesn't support use. Reconstituted or compounded preparations are the wildcard. Compounding pharmacies establish their own beyond-use dates (BUDs) based on general USP compounding chapters for nonsterile and sterile preparations, and those BUDs are frequently far shorter than a manufacturer's multi-year shelf life, sometimes days to a few weeks depending on the vehicle and whether it's sterile or nonsterile ^[2]. If your prescription came from a compounding pharmacy as part of an off-label rapamycin protocol, the paperwork that ships with it, not this article, sets the real refrigeration and expiration rules. | Form | Typical storage | Use-by after opening |

What happens if sirolimus gets too hot or freezes?

Heat is the bigger practical risk for most people, since tablets often travel in mail, cars, or gym bags. The FDA label's allowed range tops out at 30°C (86°F) for temporary excursions ^[1], which covers a hot delivery truck for a day but not weeks sitting in a mailbox in July or a glovebox in Arizona. There's no published human data quantifying exactly how much potency sirolimus loses at, say, 40°C for a week. Manufacturers test to establish shelf life under controlled conditions, not failure curves for consumers to reference. The honest, practical stance: if a shipment sat somewhere clearly outside 15-30°C for an extended period (days, not hours), treat it as compromised and contact the dispensing pharmacy rather than guessing. Underdosing an immunosuppressant because of degraded drug is not a risk worth taking, especially for anyone on it post-transplant. Freezing is generally not tested or recommended for either the tablets or solution. There's no FDA guidance suggesting freezing is safe, and absent that data the conservative rule is simple: don't freeze it, and don't store it near an ice pack in a shipping box for days if avoidable.

How long does sirolimus stay stable once dispensed?

For manufacturer-sealed Rapamune tablets, stability is governed by the printed expiration date on the bottle, generally one to a few years from manufacture depending on lot, per standard FDA drug labeling practice for oral solids ^[1]. Once the pharmacy dispenses tablets into a new container, some pharmacies also apply a shorter beyond-use date under USP General Chapter <795> for nonsterile compounding, though a straight repackage of intact manufactured tablets often just carries the original expiration or a standard one-year BUD, whichever is sooner, per USP repackaging conventions ^[2]. Oral solution has a firm 30-day clock after opening no matter what the original expiration date says ^[1]. Write the open date on the bottle. It's an easy thing to lose track of. Compounded sterile or nonsterile sirolimus preparations, which are common in off-label injectable or specialty formulations, follow USP <795> (nonsterile) or USP <797> (sterile) beyond-use date defaults, which can be as short as a few days for high-risk sterile compounds without sterility testing, or longer with validated stability testing ^[2]. This is one more reason off-label rapamycin protocols carry more logistical friction than a simple oral tablet regimen: the storage and expiration rules are pharmacy-specific rather than a single FDA number you can look up once.

Can I travel with sirolimus, and does it need a cooler bag?

Tablets don't need a cooler bag for normal travel. Since the FDA-labeled range is 20-25°C with excursions to 15-30°C ^[1], a pill organizer in a backpack or carry-on is fine for typical travel, including flights, as long as it's not sitting in checked baggage that could see extreme cargo-hold temperatures or left in a parked car. If you're flying with reconstituted or compounded product that the pharmacy has told you needs refrigeration, that's a different situation entirely. Use an insulated bag with an ice pack, and plan for TSA screening of medical liquids, which generally allows medically necessary liquids over the standard 3.4 oz limit with declaration at screening under TSA's medical exception policy for prescription medication. Either way, always keep sirolimus in its original labeled container when traveling. That's more than a customs courtesy. It's how a pharmacist or ER physician identifies your medication and dosage if there's ever a question.

Does light exposure affect sirolimus potency?

Yes, in the sense that the manufacturer instructs storage in the original container, which is designed to limit light exposure, and protection from light is a standard precaution for many oral solid drug products generally. The specific quantitative light-degradation data for sirolimus isn't broken out in the public FDA label beyond the storage instruction itself ^[1]. Practically: keep tablets in their original amber or opaque bottle rather than transferring them to a clear pill case for long-term storage, and don't leave the bottle on a sunny windowsill. A daily pill organizer for a week's dosing is fine since that's a short exposure window, not a systemic storage practice.

Is sirolimus the same as rapamycin, and does that change storage?

Sirolimus and rapamycin are the same molecule. Rapamycin was the original name for the compound discovered in soil bacteria from Easter Island (Rapa Nui), and sirolimus is the generic drug name used once it became an approved pharmaceutical. You'll also see the brand name Rapamune, plus newer branded derivatives like Fyarro (for malignant PEComa) and Hyftor (a topical formulation for tuberous sclerosis complex-related skin lesions), all built on the same active molecule ^[3][4]. Storage rules don't change based on which name is on the label. They change based on the physical formulation: tablet, oral solution, IV product, topical gel, or compounded injectable. This naming overlap causes real confusion for people researching longevity protocols, since some vendors market 'rapamycin' as though it's a separate, less regulated substance from prescription sirolimus. It isn't. Same molecule, same FDA-regulated storage science, whatever the label says.

Does storage matter differently for off-label, low-dose longevity protocols?

This is worth separating clearly, because it's the whole context most readers are actually in. FDA-approved uses for sirolimus are kidney transplant rejection prophylaxis, and for the mTOR-inhibitor derivatives, specific rare conditions like malignant PEComa (Fyarro) and tuberous sclerosis complex skin manifestations (Hyftor) ^[3][4]. Using sirolimus for aging, lifespan extension, or general longevity is entirely off-label. No regulatory body has approved it for that indication. The animal evidence behind this off-label interest is genuinely strong. The National Institute on Aging's Interventions Testing Program (ITP) found that rapamycin fed to genetically heterogeneous mice starting at 9 months of age extended median lifespan by roughly 9 to 14% in males and 13 to 21% in females depending on dose and cohort, one of the most consistently replicated lifespan-extension results the ITP has produced across multiple independent test sites ^[5]. Later ITP work also found benefits when treatment started later in life, and at intermittent dosing schedules, which is part of why the 'low-dose, intermittent, weekly' protocols became popular among off-label users ^[5]. But there is no completed human lifespan trial. None. The human data that exists is short-duration and looks at biomarkers or specific conditions, not lifespan; the PEARL trial (a phase 2 study of low-dose rapamycin in healthy adults) has reported some biomarker findings, but it was not designed or powered to measure human lifespan extension, and no study has actually done that in humans . Storage and formulation questions matter more here, not less, because off-label users are often getting compounded product from pharmacies without the decades of stability data that back FDA-approved Rapamune tablets. That's a real, practical difference, separate from the efficacy question entirely.

What are the real risks of off-label sirolimus protocols, storage aside?

Storage mistakes are a manageable, mechanical problem. The bigger risks with off-label intermittent-dosing sirolimus protocols are pharmacological, and worth stating plainly regardless of how well the drug was stored. Sirolimus is an immunosuppressant. That's not a side effect footnote, it's the core approved mechanism, used deliberately in transplant patients to prevent organ rejection . In someone without a transplant, suppressing mTOR signaling and immune function can mean slower wound healing, more frequent infections, and reduced vaccine response, and the degree of immune effect at low, intermittent longevity-protocol doses versus standard transplant doses hasn't been rigorously mapped in humans. Mouth ulcers (stomatitis) are one of the most commonly reported side effects in sirolimus's own FDA labeling, occurring in a meaningful share of transplant patients on standard dosing, and they show up anecdotally in off-label low-dose users too ^[1]. Metabolic effects are also real and documented: sirolimus can raise triglycerides and LDL cholesterol and has been associated with new-onset impaired glucose tolerance in transplant populations, changes that matter for anyone using it long-term for a supposed longevity benefit that itself remains unproven in humans ^[1]. None of this means the animal data isn't compelling. It is, particularly the ITP's repeated replication across sites and both sexes ^[5]. It means the honest picture for a longevity researcher is: strong mouse lifespan data, zero completed human lifespan trials, and a known immunosuppression and metabolic side-effect profile from decades of transplant use that off-label users are borrowing without the matched risk-benefit population.

How should I store sirolimus if I'm on a provider-reviewed protocol?

Follow the label on the container you actually received, first. If it's manufacturer-sealed Rapamune tablets, room temperature (20-25°C, excursions to 15-30°C) in the original bottle, protected from light and moisture ^[1]. If it's oral solution, room temperature after opening, used within 30 days ^[1]. If it's a compounded or reconstituted product from a specialty pharmacy, follow that pharmacy's printed beyond-use date and temperature instructions exactly, since those are formulation-specific and governed by USP compounding chapters rather than a single universal FDA number ^[2]. If you're working with a provider-reviewed pathway like the one Sirolimus Rx connects patients to, storage instructions come from the fulfilling pharmacy alongside the prescription, matched to the exact formulation and concentration dispensed. That's the safest way to avoid the guesswork inherent in general storage advice online. When in doubt about a specific bottle or vial, call the pharmacy that filled it. That's faster and more reliable than any general article, including this one. For dosing logistics beyond storage, questions about how much to take, how to reconstitute a compounded vial, injection technique, and cycle length are separate topics worth reading before starting any protocol: see Sirolimus Rx dosage, the Sirolimus Rx dosage calculator, how to reconstitute Sirolimus Rx, Sirolimus Rx how to inject, Sirolimus Rx injection sites, and Sirolimus Rx cycle length.

Frequently asked questions

Does sirolimus need to be refrigerated after opening?

Rapamune tablets don't need refrigeration at any point; store at room temperature (20-25°C). Rapamune oral solution is also kept at room temperature after opening but must be used within 1 month, per FDA labeling. Compounded or reconstituted sirolimus may need refrigeration depending on the specific pharmacy's formulation, always check that product's label.

Can sirolimus tablets be left out at room temperature?

Yes. FDA labeling specifies storage at 20-25°C (68-77°F) with allowed temporary excursions to 15-30°C (59-86°F), which is standard room temperature, not the fridge. Keep tablets in their original container away from direct light and moisture, and don't leave the bottle in a hot car or on a sunny windowsill for extended periods.

What temperature should sirolimus be stored at?

20°C to 25°C (68°F to 77°F) is the labeled range for Rapamune, with brief excursions down to 15°C or up to 30°C considered acceptable during shipping, per FDA prescribing information. This applies to tablets and, after dispensing, to oral solution. Compounded formulations may specify different, product-specific ranges.

Is sirolimus the same as rapamycin for storage purposes?

Yes, sirolimus and rapamycin are the same molecule; sirolimus is the generic drug name and rapamycin is the original compound name. Storage rules depend on the physical formulation (tablet, solution, compounded injectable), not on which name appears on the label.

How long can sirolimus oral solution be used after opening?

FDA labeling for Rapamune oral solution specifies use within 1 month (30 days) of opening the bottle. After that window, the manufacturer doesn't support continued use even if the printed expiration date on the bottle hasn't passed. Write the date you opened it on the label so you don't lose track.

Does freezing damage sirolimus?

There's no FDA guidance recommending or validating freezing for sirolimus tablets or oral solution, so the conservative approach is to avoid freezing entirely. If a shipment appears to have frozen in transit, contact the dispensing pharmacy rather than using the product, especially for anyone relying on it for transplant rejection prevention.

Do compounded sirolimus preparations have different storage rules than Rapamune?

Often yes. Compounding pharmacies assign beyond-use dates under USP General Chapters <795> (nonsterile) and <797> (sterile) compounding standards, which can be much shorter than a manufacturer's shelf life and sometimes require refrigeration. Always follow the specific label on a compounded product rather than assuming it matches manufacturer-sealed Rapamune rules.

Is sirolimus FDA-approved for anti-aging or longevity use?

No. Sirolimus is FDA-approved for kidney transplant rejection prophylaxis, and related mTOR-inhibitor products (Fyarro, Hyftor) are approved for specific rare conditions. Using it for aging or lifespan extension is entirely off-label, and no completed human trial has demonstrated lifespan extension in people.

What does the animal research actually show about rapamycin and lifespan?

The NIA's Interventions Testing Program found rapamycin extended median lifespan in genetically heterogeneous mice by roughly 9-14% in males and 13-21% in females depending on dose, replicated across multiple independent labs. It's among the most consistently reproduced lifespan results in mouse aging research, but mouse results don't guarantee equivalent human effects.

What are the main risks of off-label low-dose sirolimus use?

Immunosuppression (slower healing, higher infection risk), mouth ulcers (stomatitis), and metabolic changes including elevated triglycerides, LDL cholesterol, and impaired glucose tolerance are all documented in sirolimus's transplant-population labeling. These risks haven't been separately quantified for low-dose, intermittent longevity protocols in healthy adults.

Has any human trial shown sirolimus extends human lifespan?

No. No completed human trial has measured lifespan extension from sirolimus or rapamycin. The PEARL trial, a phase 2 study of low-dose rapamycin in healthy adults, examined biomarkers over a short duration; it was not designed to, and did not, demonstrate human lifespan extension.

Can I travel by plane with sirolimus?

Yes, tablets travel fine at normal cabin temperatures in carry-on luggage, kept in the original labeled container. If your specific prescription is a refrigerated compounded product, use an insulated bag with an ice pack and declare it as a medically necessary liquid at TSA screening, which allows exceptions to standard liquid limits for prescription medication.

Sources

1. FDA, Fyarro (sirolimus protein-bound particles for injectable suspension) approval, NDA 215696: Fyarro is FDA-approved specifically for malignant PEComa
2. FDA, Hyftor (sirolimus topical gel) approval, NDA 213648: Hyftor is FDA-approved for facial angiofibroma associated with tuberous sclerosis complex
3. National Institute on Aging, Interventions Testing Program rapamycin results summary: Rapamycin extended median lifespan roughly 9-21% in genetically heterogeneous mice across ITP cohorts
4. Harrison DE et al., Nature 460:392-395 (2009), 'Rapamycin fed late in life extends lifespan in genetically heterogeneous mice': Rapamycin extends mouse lifespan even when started later in life
5. Kaeberlein TL et al., 'The PEARL trial: a phase 2 study of low-dose rapamycin in healthy adults', PMC10665599: PEARL trial studied biomarkers in healthy adults on low-dose rapamycin, not lifespan extension